Dr Lalukota Krishna Mohan

Dr. Lalukota Krishna Mohan is a Senior Interventional Cardiologist with over 25 years of experience in advanced cardiovascular care. He has been actively involved in international research, clinical trials and cardiology conferences, with significant contributions to heart failure management and cardiac device therapy. He has also received specialized training in echocardiography, coronary angiography and complex percutaneous coronary interventions. Fluent in Telugu, English and Hindi, he focuses on comprehensive and patient-centred cardiovascular care.

Educational Qualification:

• MBBS – Gandhi Medical College, Hyderabad (1994)
• MRCP (UK) – Royal College of Physicians, London (2002)
• FRCP (London) – Royal College of Physicians, London (2018)

Professional Experience:

• Clinical Director & Senior Interventional Cardiologist – CARE Hospitals, HITEC City, Hyderabad.
• Specializes in interventional cardiology, heart failure, device therapy and complex cardiovascular interventions.
• Extensive experience in coronary and peripheral angioplasty and advanced cardiac device therapy.
• Has pioneered a dedicated Heart Failure Clinic focused on advanced heart failure treatment.
• Director – Cardiac Centre & Chief of Heart Failure and Transplant Services, Continental Hospital (2022 – January 2025).
• Consultant – Interventional Cardiologist / Heart Failure & Transplant Cardiologist, CARE Hospitals (October 2012 – February 2015; November 2019 – August 2020).
• Consultant – Interventional Cardiologist & Director of Heart Failure Services, Century Super Specialty Hospital.
• Consultant Interventional Cardiologist / Heart Failure & Device Specialist, Virinchi Hospitals.
• Worked in the United Kingdom for 15 years.

Awards and Achievements:

• Pioneered a dedicated Heart Failure Clinic in Hyderabad.
• Actively involved in international cardiology conferences, research and clinical trials.
• Presented at international forums including CCT 2019, Kobe, Japan and the Heart Failure Society of India.

Professional Memberships:

• British Society of Heart Failure (BSH)
• British Medical Association (BMA)
• European Society of Cardiology (ESC)
• Heart Failure Association – ESC (HFA)
• European Association of Percutaneous Cardiovascular Interventions (EAPCI)
• Council on Valvular Heart Disease – ESC
• Cardiological Society of India (CSI)

Research and Presentations:

• Involved in the E-ECHOES study, funded by the British Heart Foundation and the Department of Primary Care at the University of Birmingham, assessing the prevalence of heart failure among the South Asian population.
• Research activities included clinical assessment, ECG, echocardiography, questionnaires and blood sample collection.
• Top recruiter in the UK for the VERITAS and EVEREST trials, multicentre RCTs involving acute decompensated pulmonary oedema patients.
• Presented research at international conferences and cardiology forums.

Publications:

• Myelotoxicity Due to Methotrexate – An Iatrogenic Cause – European Journal of Haematology, 2003.
• Prevalence of Atrial Fibrillation in an Urban Population in India: The Nagpur Pilot Study – Heart Asia, 2016.
• Pleomorphism During Ventricular Tachycardia: A Distinguishing Feature Between Cardiac Sarcoidosis and Idiopathic VT – Pacing and Clinical Electrophysiology, 2015.
• Atrial Synchronous Left Ventricular Only Pacing with VDD Pacemaker System – A Cost Effective Alternative to Conventional Cardiac Resynchronization Therapy – Indian Heart Journal, 2014.
• Rescrewing the Embolized Duct Occluder Using the Delivery Cable – Annals of Pediatric Cardiology, 2014.
• Clinical Trials Update from the Heart Failure Society of America – European Journal of Heart Failure, 2004.
• Diagnosing Heart Failure in Primary Care: Lessons from EPICA – European Journal of Heart Failure, 2004.
• Clinical Trials Update from the American Heart Association Meeting – European Journal of Heart Failure, 2004.
• Co-author of the textbook chapter “Calcium Sensitizers” in Managing Acute Decompensated Heart Failure.